Health outcomes and healthcare resource utilization among Veterans with stage IV non-small cell lung cancer treated with second-line chemotherapy versus immunotherapy

BACKGROUND: Until recently, multi-agent chemotherapy (CT) was the standard of care for patients with advanced non-small cell lung cancer (NSCLC). Clinical trials have confirmed benefits in overall survival (OS) and progression-free survival with immunotherapy (IO) compared to CT. This study compares...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Christina D., Allo, Mina A., Gu, Lin, Vashistha, Vishal, Press, Ashlyn, Kelley, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942992/
https://www.ncbi.nlm.nih.gov/pubmed/36809528
http://dx.doi.org/10.1371/journal.pone.0282020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942992/
https://www.ncbi.nlm.nih.gov/pubmed/36809528
http://dx.doi.org/10.1371/journal.pone.0282020

Ejemplares similares